Clinical Trial Update: To Evaluate the Efficacy and Safety of KN060 in Essential Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating KN060 for efficacy and safety in patients with essential hypertension, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• KN060

Snippet

Sponsor: Suzhou Alphamab Co., Ltd. | Conditions: Hypertension | Phase 1 | Status: RECRUITING